17:05 goicolea - changes after cto recanilization
TRANSCRIPT
![Page 1: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/1.jpg)
Changes in Distal Vessels after CTO Recanalization;
Relation with Myocardial Viability
Javier GoicoleaHospital Universitario Puerta de Hierro
![Page 2: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/2.jpg)
CTO
STEMI
![Page 3: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/3.jpg)
Changes in Distal Vessels after CTO Recanalization; QCA (n=91 les)
J. Gomez-Lara et al Eurointervention 2014
![Page 4: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/4.jpg)
IVUS post/FU in 58 pts
ΔLD=0.21 ΔEEMD=0.21
ΔEEMA=0.85ΔLA=0.87
J A C C Cardiovascular Interventions, , 2 0 1 2
![Page 5: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/5.jpg)
J. Gomez-Lara et al Eurointervention 2014
Changes in Distal Vessels after CTO Recanalization; IVUS (n= 43 les)
![Page 6: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/6.jpg)
Post F-U0
0.5
1
1.5
2
2.5
3
22.25
RVD
(J Am Coll Cardiol 2012;59:711–8)
![Page 7: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/7.jpg)
Vasomotion Changes at F-U
![Page 8: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/8.jpg)
• Intense and resistant vasoconstriction
• Vessel remodeling (structural)
– Plaque volume decrease
– EEM volume enlargement
• Combination of both
Changes in Distal Vessels after CTO Recanalization
![Page 9: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/9.jpg)
Clinical Implications
• “True” distal vessel size may be difficult to determine accurately immediately after CTO recanalization (even with IVUS).
• Complete functional vessel recovery may even take longer ¿endothelial friendly stents?
• Relationship between myocardial and vascular viability …..
![Page 10: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/10.jpg)
What About Myocardial Viability?
![Page 11: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/11.jpg)
74 patients with CTO, screened from March 2010 to December 2011, were
included in a prospective protocol
47 patients underwent PCI of CTO
24 patients were included in the statistical analysis.
27 patients treated with medical therapy
8 patients refused cardiac MRI/MIBI
7 patients without successful PCI
8 patients without angiographic follow-up
What About Myocardial Viability?
![Page 12: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/12.jpg)
Demographics
n=24
Age 60±6Female gender 2 (8.3%)HBP 13 (54.2%)Dyslipidemia 19 (79.2%)Q MI 2 (8.3%)
![Page 13: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/13.jpg)
Lesion Characteristicsn=24
1 Vessels 7 29%
2 Vessels 10 42%
3 Vessels 7 29%
CTO duration (months) 35.9 23.9-155.6
Vessel
LAD 3 12.5%
LCx 5 20.8%
RCA 16 66.7%
CC
1 6 25%
2 18 75%
![Page 14: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/14.jpg)
Procedure
Stent
Paclitaxel 1
Sirolimus 1
Everolimus 14
Zotarolimus 1
Biolimus 7
Procedure time ‘ 131.7±54.6
Fluoro time ‘ 52.5±30.4
Contrast ml 243±99
![Page 15: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/15.jpg)
QCA Results
Post FU p
MLD intra Stent 2.14±0.4 1.95±0.5 0.010
MLD post Stent 1.15±0.06 1.39±0.6 0.005
Mean D post Stent 1.67±0.6 1.83±0.7 0.038
![Page 16: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/16.jpg)
Changes in QCA
+ Viability -Viability pΔMLD 0.29±0.4 0.03±0.4 0.17
Δ mean Diam 0.25±0.3 -0.19±0.2 0.010Δ mean Area 0.62±1 -0.19±0.4 0.034
![Page 17: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/17.jpg)
Univariate Analysis
OR CI P
Viability 2.67 1.09-6.52 <0.001
Creatinine <0.8 2 1.02-3.92 0.06
Age, gender, dislipidemia, cc, MLD intra and post stent.
![Page 18: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/18.jpg)
![Page 19: 17:05 Goicolea - Changes after CTO Recanilization](https://reader035.vdocuments.us/reader035/viewer/2022070518/58e5f8b11a28ab09478b5383/html5/thumbnails/19.jpg)
Conclusion
• Despite the small number of patients included, underlying myocardial viability seems to predict both functional recovery and of the vascular architecture, after CTO recanalization.
• This lends support to the hypothesis linking vascular and myocardial viability and should be taken in consideration when choosing a particular stent size.